The October 2009 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 15, Issue 4
Editorial
| Intellectual property and biotechnology innovation: To protect or not protect? | |
| Yali Friedman |
Commentary
| The correlation between medical tourism and biotechnology | |
| David G Vequist IV, Erika Valdez |
| The VC manifesto: Special pleading for a damaged cause: Commentary on Simon Witney interview | |
| William Bains |
Articles
| Innovate America: The Technology Innovation Program at NIST | |
| Andrew S Klein, Mrunal S Chapekar |
| Valuation of complex license contracts | |
| Ralph Villiger, Boris Bogdan |
| How can pharmaceutical and biotechnology companies maintain a high profitability? | |
| Klaus J Nickisch, Joachim M Greuel, Kerstin M Bode-Greuel |
| Multiyear patterns regarding the relative availability of venture capital for the US biotechnology industry | |
| J Leslie Glick |
| Building biotechnology teams: Personality does matter | |
| Anne S York, Kim A McCarthy, Todd C Darnold |
| Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement | |
| Rob Hanes, Damon Borich |
Legal and Regulatory Updates
| Legal and Regulatory Update | |
| Gerry Kamstra, John Wilkinson |
Book Reviews
| Book Review: Genomics & society: Legal, ethical and social dimensions | |
| Dominic Clark |
| Book Review: Commercialization of innovative technologies: Bringing good ideas to the marketplace | |
| Arlen D Meyers |
| Book Review: Biotech funding trends: Insights from entrepreneurs and investors | |
| J Leslie Glick |